Miliary never-smoking adenocarcinoma of the lung: strong association with epidermal growth factor receptor exon 19 deletion

J Thorac Oncol. 2011 Jan;6(1):199-202. doi: 10.1097/JTO.0b013e3181fb7cf1.

Abstract

Miliary pattern of pulmonary metastases is a rarity in patients with lung cancer. We report five cases of patients with a never-smoking adenocarcinoma of the lung with such a pattern of metastases. In the tumor cells of all five patients, epidermal growth factor receptor (EGFR) mutation gene sequencing identified a deletion in exon 19 of the EGFR gene, and all five patients had a dramatic response to EGFR tyrosine kinase inhibitors. No echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) translocation was detected. We believe that the miliary never-soking adenocarcinoma of the lung is a distinct clinically relevant subgroup of the never-smoking non-small cell lung cancer. Physician should recognize this subgroup of patients with lung cancer when facing a picture of miliary pulmonary metastases in chest x-ray or computed tomography scan in patients with a history of never smoking and consider upfront therapy with EGFR tyrosine kinase inhibitors.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Bone Neoplasms / genetics
  • Bone Neoplasms / secondary
  • Brain Neoplasms / genetics
  • Brain Neoplasms / secondary
  • Carcinoma, Acinar Cell / genetics*
  • Carcinoma, Acinar Cell / secondary
  • DNA, Neoplasm / genetics
  • ErbB Receptors / genetics*
  • Exons / genetics*
  • Female
  • Humans
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / pathology
  • Male
  • Middle Aged
  • Mutation / genetics*
  • Neoplasm Staging
  • Oncogene Proteins, Fusion / genetics
  • Polymerase Chain Reaction
  • Prognosis
  • Sequence Deletion*
  • Smoking*
  • Translocation, Genetic

Substances

  • DNA, Neoplasm
  • EML4-ALK fusion protein, human
  • Oncogene Proteins, Fusion
  • EGFR protein, human
  • ErbB Receptors